Fund Holdings — Palo Alto Investors LP

Total Portfolio Value:
$525.15M
Total Bought:
$47.08M
Total Sold:
$104.69M
Net Transaction:
-$57.61M
Notable People:
Palo Alto Investors Gp Llc
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Insmed Incorporated(INSM)1,603,465987,153-616,312$110.70M$75.31M14.34%-$35.39M
BioMarin Pharmaceutical Inc.(BMRN)1,067,266991,207-76,059$70.15M$70.07M13.34%-$83.0K
Amicus Therapeutics Inc
COM
7,662,4797,345,002-317,477$72.18M$59.94M11.41%-$12.25M
Acadia Pharmaceuticals Inc2,748,5992,663,925-84,674$50.44M$44.25M8.43%-$6.19M
United Therapeutics Corporation(UTHR)155,714105,228-50,486$54.94M$32.44M6.18%-$22.50M
Biogen Inc.(BIIB)190,148204,923+14,775$29.08M$28.04M5.34%-$1.04M
Alnylam Pharmaceuticals, Inc.(ALNY)140,68183,488-57,193$33.10M$22.54M4.29%-$10.56M
PTC Therapeutics, Inc.(PTCT)386,413404,196+17,783$17.44M$20.60M3.92%+$3.16M
Prothena Corp PlcSHS
SHS
1,737,9641,659,734-78,230$24.07M$20.54M3.91%-$3.53M
Anaptysbio Inc843,9711,020,713+176,742$11.17M$18.98M3.61%+$7.80M
NovoCure Limited(NVCR)814,1911,002,061+187,870$24.26M$17.86M3.40%-$6.41M
Sarepta Therapeutics, Inc.(SRPT)210,258210,2580$25.57M$13.42M2.56%-$12.15M
eHealth, Inc.(EHTH)1,878,1271,684,336-193,791$17.65M$11.25M2.14%-$6.40M
Iovance Biotherapeutics, Inc.(IOVA)3,041,6853,211,314+169,629$22.51M$10.69M2.04%-$11.81M
STAAR Surgical Company(STAA)500,775525,017+24,242$12.16M$9.26M1.76%-$2.91M
Agios Pharmaceuticals, Inc.(AGIO)0276,578+276,578$0$8.10M1.54%+$8.10M
Alkermes plcSHS(ALKS)289,308221,513-67,795$8.32M$7.31M1.39%-$1.01M
Gossamer Bio, Inc.(GOSS)6,277,0936,276,893-200$5.68M$6.90M1.31%+$1.23M
Align Technology Inc37,77237,7720$7.88M$6.00M1.14%-$1.88M
Syndax Pharmaceuticals, Inc.(SNDX)405,193444,367+39,174$5.36M$5.46M1.04%+$102.4K
Acelyrin Inc1,792,8951,792,8950$5.63M$4.43M0.84%-$1.20M
Dyne Therapeutics, Inc.(DYN)0333,391+333,391$0$3.49M0.66%+$3.49M
Mirum Pharmaceuticals, Inc.(MIRM)64,70064,7000$2.68M$2.91M0.56%+$239.4K
Edwards Lifesciences Corp39,47339,4730$2.92M$2.86M0.54%-$61.2K
Verve Therapeutics Inc575,817575,8170$3.25M$2.63M0.50%-$616.1K
BioNTech SEADS(BNTX)25,20625,2060$2.87M$2.30M0.44%-$577.0K
Bicycle Therapeutics Plc-AdrADS248,934248,9340$3.49M$2.11M0.40%-$1.37M
Travere Therapeutics, Inc.(TVTX)110,719110,7190$1.93M$1.98M0.38%+$55.4K
Taysha Gene Therapies, Inc.(TSHA)811,2681,419,468+608,200$1.40M$1.97M0.38%+$569.6K
Neurocrine Biosciences, Inc.(NBIX)013,334+13,334$0$1.47M0.28%+$1.47M
Nuvation Bio Inc.CL A(NUVB)772,652772,6520$2.06M$1.36M0.26%-$695.4K
Aldeyra Therapeutics, Inc.(ALDX)225,465225,4650$1.13M$1.30M0.25%+$171.4K
Karyopharm Therapeutics Inc.(KPTI)4,907,001324,032-4,582,969$3.32M$1.21M0.23%-$2.11M
Aclaris Therapeutics, Inc.(ACRS)569,832776,028+206,196$1.41M$1.19M0.23%-$225.9K
Humana Inc.(HUM)3,9853,9850$1.01M$1.05M0.20%+$43.4K
Pyxis Oncology, Inc.(PYXS)1,037,4211,037,4210$1.62M$1.02M0.19%-$601.8K
Stoke Therapeutics, Inc.(STOK)125,861125,8610$1.39M$837.0K0.16%-$551.3K
Yarrow Bioscience Inc(YARW)445,434445,4340$1.49M$703.8K0.13%-$788.4K
Abeona Therapeutics Inc.(ABEO)108,865108,8650$606.4K$518.2K0.10%-$88.2K
UroGen Pharma Ltd.(URGN)24,50024,5000$260.9K$271.0K0.05%+$10.0K
Instil Bio, Inc.(TIL)11,16511,1650$213.1K$193.8K0.04%-$19.3K
Akari Therapeutics, PlcADR(AKTX)146,024146,0240$178.1K$181.1K0.03%+$2.9K
Relmada Therapeutics, Inc.(RLMD)495,146495,1460$257.5K$133.7K0.03%-$123.8K
Generation Bio Co150,475150,4750$159.5K$60.9K0.01%-$98.6K
Jasper Therapeutics, Inc.(JSPR)30,6510-30,651$655.3K$0—-$655.3K
Nevro Corp750,3710-750,371$2.79M$0—-$2.79M
Page 1 of 1
Palo Alto Investors LP — 13F Holdings — Q1 2025 | TickerTrail